Kellie Dean

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Artificial Intelligence

Single Molecule

Palliative Care

Top Venues

Nucleic acids research

This page only lists publications with an associated author ORCID identifier.

Publications

Seodhna M Lynch, Aisling B Heeran, Caoimbhe Burke, Niamh Lynam-Lennon, Alexander J Eustace, Kellie Dean, Tracy Robson, Arman Rahman, Simone Marcone
Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference. Cancers 16 (11) (2024)
Seodhna M Lynch, Aisling B Heeran, Caoimbhe Burke, Niamh Lynam-Lennon, Alexander J Eustace, Kellie Dean, Tracy Robson, Arman Rahman, Simone Marcone
Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference. Cancers 16 (11) (2024)
Manjeet Kumar, Sushama Michael, Jesús Alvarado-Valverde, András Zeke, Tamas Lazar, Juliana Glavina, Eszter Nagy-Kanta, Juan Mac Donagh, Zsofia E Kalman, Stefano Pascarelli, Nicolas Palopoli, László Dobson, Carmen Florencia Suarez, Kim Van Roey, Izabella Krystkowiak, Juan Esteban Griffin, Anurag Nagpal, Rajesh Bhardwaj, Francesca Diella, Bálint Mészáros, Kellie Dean, Norman E Davey, Rita Pancsa, Lucía Beatriz Chemes, Toby J Gibson
ELM-the Eukaryotic Linear Motif resource-2024 update. Nucleic acids research (2023)
Caroline Conway, Denis M Collins, Amanda McCann, Kellie Dean
Research Strategies for Low-Survival Cancers. Cancers 13 (3) (2021)
Julia Samson, Magdalina Derlipanska, Oza Zaheed, Kellie Dean
Molecular and cellular characterization of two patient-derived ductal carcinoma in situ (DCIS) cell lines, ETCC-006 and ETCC-010. BMC cancer 21 (1) (2021)
Emma H Allott, Kellie Dean, Tracy Robson, Claire Meaney
Characterizing and Exploiting Tumor Microenvironments to Optimize Treatment Outcomes. Cancers 13 (22) (2021)